METTL14-m6A-FOXO3a轴调节强直性脊柱炎的自噬和炎症。

IF 4.5 3区 医学 Q2 IMMUNOLOGY Clinical immunology Pub Date : 2023-11-05 DOI:10.1016/j.clim.2023.109838
Yuting Chen , Ye Wu , Lanlan Fang , Hui Zhao , Shenqian Xu , Zongwen Shuai , Haiyang Yu , Guoqi Cai , He-Qin Zhan , Faming Pan
{"title":"METTL14-m6A-FOXO3a轴调节强直性脊柱炎的自噬和炎症。","authors":"Yuting Chen ,&nbsp;Ye Wu ,&nbsp;Lanlan Fang ,&nbsp;Hui Zhao ,&nbsp;Shenqian Xu ,&nbsp;Zongwen Shuai ,&nbsp;Haiyang Yu ,&nbsp;Guoqi Cai ,&nbsp;He-Qin Zhan ,&nbsp;Faming Pan","doi":"10.1016/j.clim.2023.109838","DOIUrl":null,"url":null,"abstract":"<div><p>The role of m6A in ankylosing spondylitis (AS) remains largely obscure. In this study, we found that m6A modification was decreased in T cells of AS, and the abnormal m6A modification was attributed to the downregulation of methyltransferase-like 14 (METTL14). METTL14 exerted a critical role in regulating autophagy activity and inflammation via targeting Forkhead box O3a (FOXO3a). Mechanistically, the loss of METTL14 decreased the expression of FOXO3a, leading to the damage of autophagic flux and the aggravation of inflammation. Inversely, the forced expression of METTL14 upregulated the expression of FOXO3a, thereby activating autophagy and alleviating inflammation. Furthermore, our results revealed that METTL14 targeted FOXO3a mRNA and regulated its expression and stability in a m6A-dependent manner. These findings uncovered the functional importance of m6A methylation mechanisms in the regulation of autophagy and inflammation, which expanded our understanding of this interaction and was critical for the development of therapeutic strategies for AS.</p></div>","PeriodicalId":10392,"journal":{"name":"Clinical immunology","volume":"257 ","pages":"Article 109838"},"PeriodicalIF":4.5000,"publicationDate":"2023-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"METTL14-m6A-FOXO3a axis regulates autophagy and inflammation in ankylosing spondylitis\",\"authors\":\"Yuting Chen ,&nbsp;Ye Wu ,&nbsp;Lanlan Fang ,&nbsp;Hui Zhao ,&nbsp;Shenqian Xu ,&nbsp;Zongwen Shuai ,&nbsp;Haiyang Yu ,&nbsp;Guoqi Cai ,&nbsp;He-Qin Zhan ,&nbsp;Faming Pan\",\"doi\":\"10.1016/j.clim.2023.109838\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The role of m6A in ankylosing spondylitis (AS) remains largely obscure. In this study, we found that m6A modification was decreased in T cells of AS, and the abnormal m6A modification was attributed to the downregulation of methyltransferase-like 14 (METTL14). METTL14 exerted a critical role in regulating autophagy activity and inflammation via targeting Forkhead box O3a (FOXO3a). Mechanistically, the loss of METTL14 decreased the expression of FOXO3a, leading to the damage of autophagic flux and the aggravation of inflammation. Inversely, the forced expression of METTL14 upregulated the expression of FOXO3a, thereby activating autophagy and alleviating inflammation. Furthermore, our results revealed that METTL14 targeted FOXO3a mRNA and regulated its expression and stability in a m6A-dependent manner. These findings uncovered the functional importance of m6A methylation mechanisms in the regulation of autophagy and inflammation, which expanded our understanding of this interaction and was critical for the development of therapeutic strategies for AS.</p></div>\",\"PeriodicalId\":10392,\"journal\":{\"name\":\"Clinical immunology\",\"volume\":\"257 \",\"pages\":\"Article 109838\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2023-11-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1521661623006010\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1521661623006010","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

m6A在强直性脊柱炎(AS)中的作用在很大程度上仍不清楚。在本研究中,我们发现AS的T细胞中m6A修饰减少,异常的m6A修饰归因于甲基转移酶样14(METTL14)的下调。METTL14通过靶向叉头盒O3a(FOXO3a)在调节自噬活性和炎症中发挥关键作用。从机制上讲,METTL14的缺失降低了FOXO3a的表达,导致自噬流量的损伤和炎症的加重。相反,METTL14的强制表达上调了FOXO3a的表达,从而激活自噬并减轻炎症。此外,我们的研究结果表明,METTL14靶向FOXO3a mRNA,并以m6A依赖的方式调节其表达和稳定性。这些发现揭示了m6A甲基化机制在自噬和炎症调节中的功能重要性,这扩大了我们对这种相互作用的理解,对AS治疗策略的制定至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
METTL14-m6A-FOXO3a axis regulates autophagy and inflammation in ankylosing spondylitis

The role of m6A in ankylosing spondylitis (AS) remains largely obscure. In this study, we found that m6A modification was decreased in T cells of AS, and the abnormal m6A modification was attributed to the downregulation of methyltransferase-like 14 (METTL14). METTL14 exerted a critical role in regulating autophagy activity and inflammation via targeting Forkhead box O3a (FOXO3a). Mechanistically, the loss of METTL14 decreased the expression of FOXO3a, leading to the damage of autophagic flux and the aggravation of inflammation. Inversely, the forced expression of METTL14 upregulated the expression of FOXO3a, thereby activating autophagy and alleviating inflammation. Furthermore, our results revealed that METTL14 targeted FOXO3a mRNA and regulated its expression and stability in a m6A-dependent manner. These findings uncovered the functional importance of m6A methylation mechanisms in the regulation of autophagy and inflammation, which expanded our understanding of this interaction and was critical for the development of therapeutic strategies for AS.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical immunology
Clinical immunology 医学-免疫学
CiteScore
12.30
自引率
1.20%
发文量
212
审稿时长
34 days
期刊介绍: Clinical Immunology publishes original research delving into the molecular and cellular foundations of immunological diseases. Additionally, the journal includes reviews covering timely subjects in basic immunology, along with case reports and letters to the editor.
期刊最新文献
A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis. Clinical characterization of NOD2 variants in patients with common variable immunodeficiency. HLA evolutionary divergence effect on bacterial infection risk in cirrhotic liver transplant candidates. Optimizing iNKT-driven immune responses against cancer by modulating CD1d in tumor and antigen presenting cells. Comparative analysis of the B cell receptor repertoire during relapse and remission in patients with multiple sclerosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1